CBLL – ceribell, inc. (US:NASDAQ)
Stock Stats
News
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older
CeriBell (NASDAQ: CBLL) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $32.00 price target on the stock.
CeriBell (NASDAQ: CBLL) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $33.00 price target on the stock.
Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference [Yahoo! Finance]
Form 144 Ceribell, Inc. Filed by: Chao Xingjuan
Form 8-K Ceribell, Inc. For: Apr 11
Form 4 Ceribell, Inc. For: Apr 01 Filed by: Foehr David
Form 4 Ceribell, Inc. For: Apr 01 Filed by: Manni Joseph S.
Form 4 Ceribell, Inc. For: Apr 01 Filed by: Woo Raymond
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.